Scienjoy Holding Corporation SJ
0.69
(0.02)
(2.82%)
as of 25 Sep
- Market cap
- $29.3M
- P/E
- 3.5×
Follow SJ
| Older periods | Mar '25 | Jun '25 | Sep '25 | Mar '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 4.26 | — | 6.30 |
P/S ratio |
0.21 | 0.18 | — | 0.29 | |
P/FCF ratio |
1.97 | 1.81 | — | 2.84 | |
P/Operating CF |
805.30 | 4.73 | — | 7.43 | |
P/B ratio |
0.24 | 0.20 | — | 0.61 | |
Price to Tangible BV |
0.48 | 0.39 | — | 10.72 | |
EV/Sales |
0.00 | (0.04) | — | 0.03 | |
EV/EBITDA |
0.00 | 0.00 | — | 0.60 | |
EV/Operating CF |
(0.04) | (0.37) | — | 0.34 | |
EV/FCF |
(0.04) | (0.38) | — | 0.34 | |
Quick Ratio |
3.09 | 3.29 | 4.33 | 3.25 | |
Current Ratio |
3.27 | 3.48 | 4.64 | 3.45 | |
Net Debt/EBITDA |
(21.85) | (13.11) | 0.00 | (29.47) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.97 | 0.95 | 0.00 | 1.20 | |
Operating CF/Net income |
0.00 | 2.26 | — | 0.00 | |
Capex/Depreciation |
— | (0.03) | — | — | |
Interest Coverage |
0.00 | 0.00 | — | 0.00 | |
Research and Development Expense of Revenue |
6.37% | 5.00% | — | 6.95% | |
Selling, General and Administrative Expense of Revenue |
8.29% | 6.40% | — | 6.79% | |
Intangible Assets out of Total Assets |
0.42 | 0.41 | 0.42 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 1.69% | — | 0.00% | |
Graham Net Nets |
1.08 | 1.36 | — | 0.75 | |
Graham Number |
0.00 | 4.15 | — | 3.05 | |
Earnings Yield |
(30.11%) | 23.46% | — | 15.87% | |
Free Cash Flow Yield |
50.75% | 55.31% | — | 35.24% | |
Revenue per Share |
1.02 | 1.17 | — | 0.98 | |
Operating CF per Share |
0.00 | 0.17 | — | 0.00 | |
Capex per Share |
0.00 | 0.00 | — | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.17 | — | 0.00 | |
Cash per Share |
0.99 | 1.02 | 0.00 | 1.15 | |
Shareholders Equity per Share |
3.90 | 4.03 | 0.00 | 2.07 | |
Interest Debt per Share |
0.00 | 0.00 | — | 0.00 | |
Book value per Share |
3.90 | 4.03 | 0.00 | 2.07 | |
Free Cash Flow |
— | 7.08 | — | — | |
Working Capital |
51.55 | 55.38 | 52.84 | 41.07 | |
Capital Expenditures |
— | (0.04) | — | — | |
Net Current Asset Value |
41.79 | 45.66 | 43.10 | 39.68 | |
EV/EBIT |
0.00 | 0.00 | — | 0.60 | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
Net Profit Margin |
(2.96%) | 6.47% | — | 3.14% | |
Price to Operating Income |
4.37 | 3.21 | — | 4.94 | |
| Other line items | |||||
Average Receivables |
29.81 | 30.12 | 30.09 | 20.52 | |
Average Payables |
5.85 | 5.17 | 3.76 | 3.79 | |
Average Assets |
192.99 | 195.77 | 193.70 | 152.61 | |
Average Common Equity |
158.84 | 163.84 | 166.79 | 128.43 |
Columns are period end dates